Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
1.
Can J Physiol Pharmacol ; 88(9): 888-98, 2010 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-20921975

RESUMO

The aim of the present study was to investigate the therapeutic effect and mechanism of proanthocyanidins from grape seed (GSPE) in the treatment of recurrent ulcerative colitis (UC) in rats. To induce recurrent colitis, rats were instilled with 2,4,6-trinitrobenzenesulfonic acid (TNBS) (80 mg/kg) into the colon through the cannula in the first induced phase, and then the rats were instilled a second time with TNBS (30 mg/kg) into the colon on the sixteenth day after the first induction UC. Rats were intragastrically administered GSPE (200 mg/kg) per day for 7 days after twice-induced colitis by TNBS. Sulfasalazine at 500 mg/kg was used as a positive control drug. Rats were killed 7 days after GSPE treatment. The colonic injury and inflammation were assessed by macroscopic and macroscopic damage scores, colon weight/length ratio (mg/cm), and myeloperoxidase activity. Then, superoxide dismutase, glutathione peroxidase, inducible nitric oxide synthase (iNOS) activities, and the levels of malonyldialdehyde, glutathione, and nitric oxide in serum and colonic tissues were measured. Compared with the recurrent UC group, GSPE treatment facilitated recovery of pathologic changes in the colon after induction of recurrent colitis, as demonstrated by reduced colonic weight/length ratio and macroscopic and microscopic damage scores. The myeloperoxidase and iNOS activities with malonyldialdehyde and nitric oxide levels in serum and colon tissues of colitis rats were significantly decreased in the GSPE group compared with those in the recurrent UC group. In addition, GSPE treatment was associated with notably increased superoxide dismutase, glutathione peroxidase activities, and glutathione levels of colon tissues and serum of rats. GSPE exerted a protective effect on recurrent colitis in rats by modifying the inflammatory response, inhibiting inflammatory cell infiltration and antioxidation damage, promoting damaged tissue repair to improve colonic oxidative stress, and inhibiting colonic iNOS activity to reduce the production of nitric oxide.


Assuntos
Antiulcerosos/uso terapêutico , Colite Ulcerativa/tratamento farmacológico , Extrato de Sementes de Uva/uso terapêutico , Proantocianidinas/uso terapêutico , Animais , Anti-Inflamatórios não Esteroides/farmacologia , Anti-Inflamatórios não Esteroides/uso terapêutico , Antiulcerosos/farmacologia , Colite Ulcerativa/induzido quimicamente , Colite Ulcerativa/metabolismo , Colite Ulcerativa/patologia , Colo/enzimologia , Colo/metabolismo , Colo/patologia , Glutationa/sangue , Glutationa/metabolismo , Extrato de Sementes de Uva/farmacologia , Masculino , Malondialdeído/sangue , Malondialdeído/metabolismo , Infiltração de Neutrófilos/efeitos dos fármacos , Óxido Nítrico/sangue , Óxido Nítrico/metabolismo , Óxido Nítrico Sintase Tipo II/sangue , Óxido Nítrico Sintase Tipo II/metabolismo , Tamanho do Órgão , Oxirredutases/sangue , Oxirredutases/metabolismo , Peroxidase/metabolismo , Proantocianidinas/farmacologia , Distribuição Aleatória , Ratos , Ratos Wistar , Prevenção Secundária , Índice de Gravidade de Doença
2.
Clin Toxicol (Phila) ; 55(8): 939-940, 2017 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-28463024

RESUMO

Iodixanol is a non-ionic contrast medium for general vascular use. The most common adverse effects from iodixanol include skin rashes, hives, erythema, itching, and angioedema. To date, there have been no reports of delayed genital blisters of iodixanol. In this report, we describe a patient in whom iodixanol induced delayed genital blisters one day after digital subtraction angiography.


Assuntos
Angiografia Digital/efeitos adversos , Vesícula/induzido quimicamente , Meios de Contraste/efeitos adversos , Toxidermias/etiologia , Hipersensibilidade Tardia/induzido quimicamente , Doenças do Pênis/induzido quimicamente , Pele/efeitos dos fármacos , Ácidos Tri-Iodobenzoicos/efeitos adversos , Antialérgicos/uso terapêutico , Vesícula/diagnóstico , Vesícula/tratamento farmacológico , Toxidermias/diagnóstico , Toxidermias/tratamento farmacológico , Humanos , Hipersensibilidade Tardia/diagnóstico , Hipersensibilidade Tardia/tratamento farmacológico , Masculino , Pessoa de Meia-Idade , Doenças do Pênis/diagnóstico , Doenças do Pênis/tratamento farmacológico , Fatores de Risco , Pele/patologia , Fatores de Tempo , Resultado do Tratamento
3.
Int Immunopharmacol ; 14(4): 620-8, 2012 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-23069381

RESUMO

Increased reactive oxygen species (ROS) such as superoxide have been implicated as causal elements of oncogenesis. A variety of cancers have displayed changes in steady-state levels of key antioxidant enzymes, with the mitochondrial form of superoxide dismutase (MnSOD) being commonly implicated. Increasing MnSOD expression suppresses the malignant phenotype in various cancer cell lines and suppresses tumor formation in xenograft and transgenic mouse models. In this study, we examined the anti-proliferation effect of mimic of manganese superoxide dismutase (MnSODm) on human non-Hodgkin lymphoma Raji cells. The results showed that MnSODm significantly reduced the proliferation of Raji cells in a concentration and a time-dependent manner. By flow cytometric analysis, we found that MnSODm treatment resulted in an increased apoptosis in Raji cells. MnSODm also increased the production of ROS and the expression levels of cleaved caspase-9, caspase-3, poly (ADP-ribose) polymerase (PARP) and Bax in Raji cells. Moreover, the expression of Bcl-2 protein showed down-regulation in the MnSODm treatment group. In addition, MnSODm significantly elevated the level of cytochrome c in cytosol. These findings suggest that the activation of the mitochondrial pathway is involved in MnSODm-induced apoptosis in Raji cells.


Assuntos
Apoptose/efeitos dos fármacos , Superóxido Dismutase/metabolismo , Western Blotting , Caspase 3/genética , Caspase 3/metabolismo , Linhagem Celular Tumoral , Proliferação de Células , Citocromos c/metabolismo , Ativação Enzimática , Humanos , Linfoma não Hodgkin , Mitocôndrias/metabolismo , Proteínas Proto-Oncogênicas c-bcl-2/genética , Proteínas Proto-Oncogênicas c-bcl-2/metabolismo , Espécies Reativas de Oxigênio , Proteína X Associada a bcl-2/genética , Proteína X Associada a bcl-2/metabolismo
4.
Arch Pharm Res ; 35(7): 1231-9, 2012 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-22864746

RESUMO

Ulcerative colitis (UC) is characterized by oxidative and nitrosative stress and neutrophil infiltration. In the present study, we aimed to investigate the therapeutic effect of ginsenoside Rd (GRd) in rats with 2,4,6-trinitrobenzenesulfonic acid (TNBS)-induced recurrent UC. After UC was twice-induced by intracolonic injection of TNBS, rats were intragastrically administered different doses of GRd per day for 7 days. The colonic lesions and inflammation were evaluated both histologically and biochemically. Compared with the TNBS group, GRd treatment facilitated recovery of pathologic changes in the colon after induction of recurrent UC, as evidenced by a significant reduction of colonic weight/length ratio and macroscopic and microscopic damage scores (p < 0.01). The myeloperoxidase and inducible nitric oxide synthase activities with malonyldialdehyde and nitric oxide levels in colonic tissues were significantly decreased in the GRd group compared with those in the TNBS group (p < 0.01). GRd treatment was associated with remarkably increased superoxide dismutase and glutathione peroxidase activities. Results showed a valuable effect of GRd against TNBS-induced recurrent UC by inhibiting neutrophil infiltration and promoting the antioxidant capacity of the damaged colonic tissue.


Assuntos
Anti-Inflamatórios/farmacologia , Colite Ulcerativa/tratamento farmacológico , Fármacos Gastrointestinais/farmacologia , Ginsenosídeos/farmacologia , Ácido Trinitrobenzenossulfônico , Animais , Biomarcadores/metabolismo , Colite Ulcerativa/induzido quimicamente , Colite Ulcerativa/metabolismo , Colite Ulcerativa/patologia , Colo/efeitos dos fármacos , Colo/metabolismo , Colo/patologia , Modelos Animais de Doenças , Glutationa Peroxidase/metabolismo , Masculino , Malondialdeído/metabolismo , Infiltração de Neutrófilos/efeitos dos fármacos , Óxido Nítrico/metabolismo , Óxido Nítrico Sintase Tipo II/metabolismo , Estresse Oxidativo/efeitos dos fármacos , Peroxidase/metabolismo , Ratos , Ratos Wistar , Recidiva , Superóxido Dismutase/metabolismo , Fatores de Tempo
5.
Int Immunopharmacol ; 12(2): 408-14, 2012 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-22227208

RESUMO

In this study, we investigated the effects and the protective mechanism of ginsenoside Rd (GRd) which has been identified as one of the effective compounds from ginseng on relapsing colitis model induced by 2,4,6-trinitrobenzenesulfonic acid (TNBS) in rats. After inducing relapsing colitis in experimental rats on two occasions by intracolonic injection of TNBS, GRd (10, 20 and 40 mg/kg) was administered to experimental colitis rats for 7 days. The inflammatory degree was assessed by macroscopic score, histology and myeloperoxidase (MPO) activity. The levels of proinflammatory cytokines, such as TNF-α, IL-1ß, and IL-6 were determined by ELISA. Mitogen-activated protein kinase (MAPK) phosphorylation was analyzed by western blotting method. The results showed that GRd markedly attenuates the inflammatory response to TNBS-induced relapsing colitis, as evidenced by improved signs, increased body weight, decreased colonic weight/length ratio, reduced colonic macroscopic and microscopic damage scores, inhibited the activity of MPO, lowered proinflammatory cytokine levels and suppressed phosphorylation of p38 and JNK. The possible mechanism of protection on experimental colitis after GRd administration was that it could reduce the accumulation of leukocytes and down-regulate multiple proinflammatory cytokines through modulation of JNK and p38 activation.


Assuntos
Colite/tratamento farmacológico , Ginsenosídeos/farmacologia , Sistema de Sinalização das MAP Quinases/efeitos dos fármacos , Animais , Peso Corporal/efeitos dos fármacos , Colite/induzido quimicamente , Colite/enzimologia , Colite/metabolismo , Colo/efeitos dos fármacos , Colo/metabolismo , Regulação para Baixo/efeitos dos fármacos , Interleucina-1beta/antagonistas & inibidores , Interleucina-1beta/metabolismo , Interleucina-6/antagonistas & inibidores , Interleucina-6/metabolismo , Leucócitos/efeitos dos fármacos , Leucócitos/metabolismo , MAP Quinase Quinase 4/metabolismo , Masculino , Proteínas Quinases Ativadas por Mitógeno/metabolismo , Peroxidase/antagonistas & inibidores , Peroxidase/metabolismo , Fosforilação/efeitos dos fármacos , Ratos , Ratos Wistar , Ácido Trinitrobenzenossulfônico , Fator de Necrose Tumoral alfa/antagonistas & inibidores , Fator de Necrose Tumoral alfa/metabolismo , Proteínas Quinases p38 Ativadas por Mitógeno/metabolismo
6.
Int Immunopharmacol ; 11(10): 1620-7, 2011 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-21642017

RESUMO

The aim of this study was to elucidate the molecular mechanisms involved in the therapeutic effects of proanthocyanidins from grape seeds (GSPE) on recurrent ulcerative colitis (UC) in rats. GSPE in doses of 100, 200, and 400mg/kg were intragastrically administered per day for 7 days after recurrent colitis was twice-induced by TNBS. The levels of GSH, as well as the activity of GSH-Px and SOD in colon tissues were measured by biochemical methods. The expression levels of tumor necrosis factor-α (TNF-α) and the nuclear translocation levels of nuclear factor-kappa B (NF-κB) in the colon tissues were measured by enzyme-linked immunosorbent assay methods. Western blotting analysis was used to determine the protein expression levels of inhibitory kappa B-alpha (IκBα), inhibitor kappa B kinase (IKKα/ß), phosphorylated IκBα and phosphorylated IKKα/ß. GSPE treatment was associated with a remarkable increased the activity of GSH-Px and SOD with GSH levels in TNBS-induced recurrent colitis rats as compared to the model group. GSPE also significantly reduced the expression levels of TNF-α, p-IKKα/ß, p-IκBα and the translocation of NF-κB in the colon mucosa. GSPE exerted a protective effect on recurrent colitis in rats by modifying the inflammatory response and promoting damaged tissue repair to improve colonic oxidative stress. Moreover, GSPE inhibited the TNBS-induced inflammatory of recurrent colitis though blocking NF-κB signaling pathways.


Assuntos
Colite Ulcerativa/tratamento farmacológico , Colo/efeitos dos fármacos , NF-kappa B/metabolismo , Proantocianidinas/administração & dosagem , Vitis , Animais , Colite Ulcerativa/induzido quimicamente , Colite Ulcerativa/imunologia , Colo/metabolismo , Colo/patologia , Modelos Animais de Doenças , Humanos , Imunomodulação , Inflamação , Masculino , Estresse Oxidativo/efeitos dos fármacos , Proantocianidinas/efeitos adversos , Ratos , Ratos Wistar , Recidiva , Sementes , Transdução de Sinais/efeitos dos fármacos , Transdução de Sinais/imunologia , Superóxido Dismutase/metabolismo , Superóxido Dismutase-1 , Ácido Trinitrobenzenossulfônico/administração & dosagem , Fator de Necrose Tumoral alfa/genética , Fator de Necrose Tumoral alfa/metabolismo , Vitis/imunologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA